Among these USPs, USP7 is one of the most well-characterized as a highly promising target for a variety of cancers, while increasing attention has been drawn to USP22 as another potential target for the development of anticancer therapeutics because of its multiple roles in cancer progress and immune response. This evidence concerns the gene USP22 and cancer.